CP-506

N/A

Report date: 2023/09/22 09:34:40
NME

Base Information

Drug NameCP-506
Drug Alias NameCP-506
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell death stimulantsDNA inhibitorsAlkylating agents
TargetsDNA
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Auckland
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A